These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10881160)
21. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy]. Germani C; Montanari L; Petraroja A Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905 [No Abstract] [Full Text] [Related]
22. Counterfeiting and piracy of pharmaceuticals. Grackin A IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698 [No Abstract] [Full Text] [Related]
23. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices. Moken MC Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247 [No Abstract] [Full Text] [Related]
24. [Public production of medicines in Brazil: an overview]. de Oliveira EA; Labra ME; Bermudez J Cad Saude Publica; 2006 Nov; 22(11):2379-89. PubMed ID: 17091175 [TBL] [Abstract][Full Text] [Related]
25. [Prices of pharmaceutical preparations in Denmark until 1645: a study of the legislation for stipulating the consumer price of drugs]. Kruse PR Theriaca; 1991 Oct; 27():3-315. PubMed ID: 11640853 [No Abstract] [Full Text] [Related]
26. America's first drug regulation regime: the rise and fall of the Import Drug Act of 1848. Heath WJ Food Drug Law J; 2004; 59(1):169-99. PubMed ID: 15212037 [No Abstract] [Full Text] [Related]
27. New rules for US drug reimbursement. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382 [No Abstract] [Full Text] [Related]
28. An audience with James Greenwood. Greenwood J Nat Rev Drug Discov; 2008 Jun; 7(6):470. PubMed ID: 18511925 [No Abstract] [Full Text] [Related]
29. The new drug policy. Dutta GP J Indian Med Assoc; 1987 Nov; 85(11):321-3. PubMed ID: 3448133 [No Abstract] [Full Text] [Related]
30. [Liability for drug-related damage by the pharmaceutical industry and the physician]. Dahse G Beitr Gerichtl Med; 1982; 40():21-2. PubMed ID: 7165639 [No Abstract] [Full Text] [Related]
31. Counterfeit drugs: defining the problem and finding solutions. Wertheimer AI; Santella TM Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440 [TBL] [Abstract][Full Text] [Related]
32. Drug policy in Bangladesh. Hasan M; Islam N Trop Gastroenterol; 1987; 8(1):3-8. PubMed ID: 3603683 [No Abstract] [Full Text] [Related]
33. A tough market. Ridley-Smith RM N Z Med J; 2007 Aug; 120(1260):U2699. PubMed ID: 17726506 [No Abstract] [Full Text] [Related]
34. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684 [TBL] [Abstract][Full Text] [Related]
35. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
36. National drug quality assurance system. Wijesekera T Ceylon Med J; 1993 Jun; 38(2):58-60. PubMed ID: 8370088 [No Abstract] [Full Text] [Related]
37. Public policies and the health of children. Goresky GV CMAJ; 1988 Jan; 138(1):14. PubMed ID: 3334910 [No Abstract] [Full Text] [Related]
38. The menace of substandard drugs. Roy J World Health Forum; 1994; 15(4):406-7. PubMed ID: 7999239 [TBL] [Abstract][Full Text] [Related]
39. [Drug samples for physicians]. Schulz G Ther Ggw; 1969 Feb; 108(2):299-302. PubMed ID: 5792520 [No Abstract] [Full Text] [Related]
40. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report. WHO Expert Committee on Specifications for Pharmaceutical Preparations World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]